The first appointmentCommercial leadership for EMEA
Cell Signaling Technology (CST) is a private, family-owned company, founded by scientists in 1999 and headquartered in Massachusetts. It develops antibodies and research tools used in scientific discovery and drug development.
In late 2023, Wenham Carter supported the appointment of CST’s General Manager, EMEA, who has since been promoted to SVP Global Sales as well. The role leads the management and growth of CST’s operations across the region, including market-specific sales strategies, deeper customer engagement and entry into new territories.
That appointment was the start of a continuing relationship focused on supporting CST’s growth and strategic priorities. Wenham Carter has also supported further commercial appointments within CST’s account management function.





